Nivolumab-based treatment (N+AVD) improves progression-free survival in advanced-stage Hodgkin’s lymphoma patients compared ...
Discover a study that aims to customise CIC profiles for patients, providing insights into which stages of the cycle are most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback